-
To penetrate crowded GLP-1 field, Rivus Pharma is taking a metabolic approach
29 Mar 2024 13:43 GMT
… drugmakers can’t make enough GLP-1s like Ozempic, Wegovy, … rate, according to Dallas. GLP-1 agonists work by mimicking … began looking at combining its GLP-1 blockbuster Mounjaro, which exceeded … scaling the organization toward an IPO and going public, and …
-
Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
26 Mar 2024 12:51 GMT
… 139, a miniature, subdermal GLP-1 implant in development for … 139, a miniature, subdermal GLP-1 implant in development … to proceed with an initial public offering for wholly owned subsidiary Cortigent … are miniature, six-month, GLP-1 implants in development …
-
Health News Roundup: Gilead-backed Kyverna Therapeutics aims for $857.3 million valuation in upsized IPO; Lilly expects strong 2024 profit on rising demand for weight-loss drug and more
06 Feb 2024 13:02 GMT
… 3 million valuation in upsized IPO
Kyverna Therapeutics expects up … valuation in its U.S. initial public offering (IPO), the biotechnology company said … the pricing of its IPO and now plans to raise … gut hormones to fight obesity, GLP-1 and GIP. (With …
-
Oral Weight-Loss Drug Developer Kallyope Exploring IPO
23 Jan 2024 23:58 GMT
… loss drugs, is exploring an initial public offering, according to people familiar … . The Kallyope treatments stimulate GLP-1 and several other hormones … to the company.
An IPO by Kallyope would add momentum … was the slowest year for IPOs since 2009 as the …
-
BioLingus (Cayman) Ltd Plans $7 Million IPO for January 31st (SUBL)
19 Jan 2024 06:32 GMT
… million in an initial public offering on Wednesday, January 31st, IPO Scoop reports. … of their company for its IPO: “We are an exempted … commercial glucagon-like peptide (GLP-1) receptor protein product … initially – and raised its assumed IPO price to $20.00 – …
-
CG Oncology Files for IPO, First Such Filing of 2024
05 Jan 2024 21:54 GMT
… The company laid out its initial public offering in a document filed with … Carmot Therapeutics also entered the IPO game in November 2023 as … advantage of the red hot GLP-1 market. Endpoints News … that Fractyl Health revealed its IPO plans in mid-December …
-
STAT+: Why CG Oncology will be the first test of 2024’s IPO waters
04 Jan 2024 17:08 GMT
… against the use of its GLP-1 drugs Mounjaro and Zepbound … rounds for newfangled startups. But IPOs, an integral part of … CG Oncology, which filed its IPO paperwork with the SEC yesterday … see many more startups attempting IPOs.
More reads
Canada approves Pfizer …
-
Fractyl Health files for IPO to back obesity gene therapy, seeking to replicate GLP-1 success with one-time treatment
15 Dec 2023 00:16 GMT
A week after one obesity biotech, Carmot Therapeutics, backed out of its IPO plans in favor of a $2.7 billion sale to Roche, another announced plans to go public on Nasdaq.
The company, Fractyl Health, had filed to go public in 2022 …
-
Playing in the Hot Obesity Market, Carmot Braves Chilly IPO Waters
20 Nov 2023 13:43 GMT
… filed for an initial public offering (IPO), banking on its pipeline of GLP-1 agonists … expects to wrap up its IPO before the year closes, … an orally available small-molecule GLP-1 agonist for the … by Endpoints News, the IPO drought is likely to continue …
-
Vivani Medical Announces Public Filing of Registration Statement for the Proposed Initial Public Offering of Cortigent, Inc., a Subsidiary Advancing the Business of its Neuromodulation Division
21 Mar 2023 11:43 GMT
… running manager for the proposed initial public offering.
A registration statement relating … is a miniature, 6-month GLP-1 implant under investigation for … technology, strategy and the proposed initial public offering of Cortigent. Forward-looking statements …